FDA PERSPECTIVES ON THE USE OF TERATOLOGY DATA FOR HUMAN RISK ASSESSMENT

被引：38

|

作者：

FRANKOS, VH ^{[1
]}

机构：

[1] US FDA,WASHINGTON,DC 20204

来源：

FUNDAMENTAL AND APPLIED TOXICOLOGY | 1985年 / 5卷 / 04期

关键词：

D O I：

10.1016/0272-0590(85)90185-X

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

引用

收藏

页码：615 / 625

页数：11

相关论文

共 50 条

[1] PERSPECTIVES IN HUMAN TERATOLOGY 1965
DRISCOLL, SG
[J]. ANESTHESIA AND ANALGESIA CURRENT RESEARCHES, 1966, 45 (01): : 9 - &
[2] USE OF CELL-PROLIFERATION DATA IN CANCER RISK ASSESSMENT - FDA VIEW
SCHEUPLEIN, RJ
[J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1993, 101 : 139 - 141
[3] UNITED-STATES FDA HUMAN TERATOLOGY INFORMATION
ROSA, FW
[J]. TERATOLOGY, 1987, 36 (01) : A14 - A15
[4] Perspectives on the use of the baboon in embryology and teratology research
Hendrickx, AG
Peterson, PE
[J]. HUMAN REPRODUCTION UPDATE, 1997, 3 (06) : 575 - 592
[5] Integration of Animal and Human Data into Pregnancy and Lactation Risk Assessment: US FDA Perspective
Sahin, L.
[J]. BIRTH DEFECTS RESEARCH, 2019, 111 (09): : 464 - 464
[6] FDA to use risk-based plant assessment
不详
[J]. TCE, 2004, (761): : 11 - 11
[7] The use of human experience data in the EU risk assessment process
Money, Chris D.
[J]. RISK ANALYSIS, 2007, 27 (02) : 387 - 396
[8] Achieving a consictent use of human data in risk assessment and management
Money, Ch.
[J]. TOXICOLOGY LETTERS, 2005, 158 : S27 - S27
[9] Human Health Risk Assessment Perspectives
Guyton, K. Z.
Jinot, J.
Hogan, K. A.
Gwinn, M. R.
Dzubow, R. C.
Chiu, W. A.
[J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2013, 54 : S22 - S22
[10] Integration of human biomonitoring exposure data into risk assessment: HESI initiatives and perspectives
Doerrer, Nancy G.
[J]. INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2007, 210 (3-4) : 247 - 251

← 1 2 3 4 5 →